162 related articles for article (PubMed ID: 36744447)
1. Clinicopathological and prognostic value of chemokine receptor CCR7 expression in head and neck squamous cell carcinoma: a systematic review and meta-analysis.
Elmakaty I; Elsayed B; Elmarasi M; Kujan O; Malki MI
Expert Rev Anticancer Ther; 2023 Apr; 23(4):443-453. PubMed ID: 36744447
[TBL] [Abstract][Full Text] [Related]
2. Squamous cell carcinoma antigen as a prognostic marker and its correlation with clinicopathological features in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
Travassos DC; Fernandes D; Massucato EMS; Navarro CM; Bufalino A
J Oral Pathol Med; 2018 Jan; 47(1):3-10. PubMed ID: 28600896
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological significance of chemokine receptor (CCR1, CCR3, CCR4, CCR5, CCR7 and CXCR4) expression in head and neck squamous cell carcinomas.
González-Arriagada WA; Lozano-Burgos C; Zúñiga-Moreta R; González-Díaz P; Coletta RD
J Oral Pathol Med; 2018 Sep; 47(8):755-763. PubMed ID: 29797610
[TBL] [Abstract][Full Text] [Related]
4. The prognostic role of C-reactive protein in patients with head and neck squamous cell carcinoma: A meta-analysis.
Chen Y; Cong R; Ji C; Ruan W
Cancer Med; 2020 Dec; 9(24):9541-9553. PubMed ID: 33201589
[TBL] [Abstract][Full Text] [Related]
5. Expression of chemokine receptor CCR7 is a negative prognostic factor for patients with gastric cancer: a meta-analysis.
Du P; Liu Y; Ren H; Zhao J; Zhang X; Patel R; Hu C; Gan J; Huang G
Gastric Cancer; 2017 Mar; 20(2):235-245. PubMed ID: 26984468
[TBL] [Abstract][Full Text] [Related]
6. The XRCC1 Arg194Trp polymorphism was associated with the risk of head and neck squamous cell carcinoma development: Results from a systematic review and meta-analysis.
Mohtasham N; Najafi-Ghobadi K; Abbaszadeh H
Cancer Rep (Hoboken); 2023 Mar; 6(3):e1776. PubMed ID: 36573562
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic value of circRNAs expression in head and neck squamous cell carcinoma: A meta-analysis.
Feng H; Wang D; Liu J; Zou L; Xu S; Liang Z; Qin G
J Clin Lab Anal; 2022 Jul; 36(7):e24496. PubMed ID: 35595945
[TBL] [Abstract][Full Text] [Related]
8. The prognostic and predictive value of excision repair cross-complementation group 1 (ERCC1) protein in 1288 patients with head and neck squamous cell carcinoma treated with platinum-based therapy: a meta-analysis.
Bišof V; Zajc Petranović M; Rakušić Z; Samardžić KR; Juretić A
Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2305-17. PubMed ID: 26179868
[TBL] [Abstract][Full Text] [Related]
9. The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
Yang WF; Wong MCM; Thomson PJ; Li KY; Su YX
Oral Oncol; 2018 Nov; 86():81-90. PubMed ID: 30409325
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological and prognostic significance of circulating tumor cells in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
Xun Y; Cao Q; Zhang J; Guan B; Wang M
Oral Oncol; 2020 May; 104():104638. PubMed ID: 32182549
[TBL] [Abstract][Full Text] [Related]
11. Utility of modified Glasgow prognostic score for head and neck squamous cell carcinoma: Systematic review and meta-analysis.
Luan CW; Kuo LT; Wang YT; Liao CT; Kang CJ; Lee YC; Chen KY; Lai CH; Tsai YH; Huang EI; Tsai MS; Hsu CM; Chang GH; Tsai YT
Head Neck; 2023 Jul; 45(7):1856-1867. PubMed ID: 37161915
[TBL] [Abstract][Full Text] [Related]
12. Programmed Cell Death Ligand 1 Expression on Immune Cells and Survival in Patients With Nonmetastatic Head and Neck Cancer: A Systematic Review and Meta-analysis.
Blažek T; Petráš M; Knybel L; Cvek J; Soumarová R
JAMA Netw Open; 2023 Mar; 6(3):e236324. PubMed ID: 37000447
[TBL] [Abstract][Full Text] [Related]
13. The prognostic role of NK cells and their ligands in squamous cell carcinoma of the head and neck: a systematic review and meta-analysis.
Bisheshar SK; De Ruiter EJ; Devriese LA; Willems SM
Oncoimmunology; 2020; 9(1):1747345. PubMed ID: 32363116
[No Abstract] [Full Text] [Related]
14. The Association and Clinical Significance of CDKN2A Promoter Methylation in Head and Neck Squamous Cell Carcinoma: a Meta-Analysis.
Zhou C; Shen Z; Ye D; Li Q; Deng H; Liu H; Li J
Cell Physiol Biochem; 2018; 50(3):868-882. PubMed ID: 30355925
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological and prognostic significance of the long non-coding RNA HOTAIR high expression in head and neck squamous cell carcinoma: a systematic review and meta-analysis.
Yang G; Huang T; Wu Y; Wang J; Pan Z; Chen Y; Pan F; Wang Y
Transl Cancer Res; 2022 Aug; 11(8):2536-2552. PubMed ID: 36093512
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of Microvessel Density in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis.
Dong Y; Ma G; Liu Y; Lu S; Liu L
Dis Markers; 2020; 2020():8842795. PubMed ID: 33062071
[TBL] [Abstract][Full Text] [Related]
17. Expression of CC-chemokine receptor 7 (CCR7) and CXC-chemokine receptor 4 (CXCR4) in head and neck squamous cell carcinoma.
Ueda M; Shimada T; Goto Y; Tei K; Nakai S; Hisa Y; Kannagi R
Auris Nasus Larynx; 2010 Aug; 37(4):488-95. PubMed ID: 20036791
[TBL] [Abstract][Full Text] [Related]
18. TERT promoter mutations in head and neck squamous cell carcinoma: A systematic review and meta-analysis on prevalence and prognostic significance.
Boscolo-Rizzo P; Tirelli G; Polesel J; Sia E; Phillips V; Borsetto D; De Rossi A; Giunco S
Oral Oncol; 2023 May; 140():106398. PubMed ID: 37075587
[TBL] [Abstract][Full Text] [Related]
19. The Prognostic Role of miR-31 in Head and Neck Squamous Cell Carcinoma: Systematic Review and Meta-Analysis with Trial Sequential Analysis.
Dioguardi M; Spirito F; Sovereto D; Alovisi M; Aiuto R; Garcovich D; Crincoli V; Laino L; Cazzolla AP; Caloro GA; Di Cosola M; Ballini A; Lo Muzio L; Troiano G
Int J Environ Res Public Health; 2022 Apr; 19(9):. PubMed ID: 35564727
[TBL] [Abstract][Full Text] [Related]
20. Prognostic and Clinicopathological Significance of FADD Upregulation in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.
González-Moles MÁ; Ayén Á; González-Ruiz I; de Porras-Carrique T; González-Ruiz L; Ruiz-Ávila I; Ramos-García P
Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32847023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]